APA aipamena

Koeth, R. A., Levison, B. S., Culley, M. K., Buffa, J. A., Wang, Z., Gregory, J. C., . . . Hazen, S. L. (2014). γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab.

Chicago Style aipamena

Koeth, Robert A., et al. "γ–Butyrobetaine Is a Pro-atherogenic Intermediate in Gut Microbial Metabolism of L-carnitine to TMAO." Cell Metab 2014.

MLA aipamena

Koeth, Robert A., et al. "γ–Butyrobetaine Is a Pro-atherogenic Intermediate in Gut Microbial Metabolism of L-carnitine to TMAO." Cell Metab 2014.